You are currently viewing the printable version of this article, to return to the normal page, please click here.

EU opens antitrust probe into Novartis, J&J

Question of the Day

What has been the biggest debacle on Obama's watch?

View results

BRUSSELS (AP) - The European Union is investigating whether drug companies Novartis and Johnson & Johnson colluded to keep a generic painkiller out of the Dutch market, the bloc's antitrust watchdog said Friday.

The European Commission is assessing whether contractual arrangements between the two companies "may have had the object or effect of hindering the entry on to the market of generic versions of Fentanyl."

Fentanyl is a strong painkiller for chronic pain.

Novartis spokesman Eric Althoff confirmed the probe, but added "we don't comment on ongoing procedures." The Basel-based company reports its third-quarter results Tuesday.

The Commission said the investigation was triggered by its own inquiry into the ability of generics _ cheaper versions of medications that are no longer protected by patents _ to enter the market.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Comments
blog comments powered by Disqus
TWT Video Picks